Back to Browse Journals » Vascular Health and Risk Management » Volume 4 » Issue 1

Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention

Authors Cesare Cuspidi, Francesca Negri, Alberto Zanchetti

Published 8 February 2008 Volume 2008:4(1) Pages 67—73

DOI https://doi.org/10.2147/VHRM.S1899

Cesare Cuspidi1,2, Francesca Negri2, Alberto Zanchetti3

1Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Milan, Italy; 2Policlinico di Monza; 3Centro Interuniversitario di Fisiologia Clinica e Ipertensione, Università di Milano, and Istituto Auxologico Italiano, Milan, Italy

Abstract: Left ventricular hypertrophy (LVH) and atrial fibrillation (AF) are strong predictors of cardiovascular (CV) morbidity and mortality, independently of blood pressure levels and other modifiable and nonmodifiable risk factors. The actions of circulating and tissue angiotensin II, mediated by AT1 receptors, play an important role in the development of a wide spectrum of cardiovascular alterations, including LVH, atrial enlargement and AF. Growing experimental and clinical evidence suggests that antihypertensive drugs may exert different effects on LVH regression and new onset AF in the setting of arterial hypertension. Since a number of large and adequately designed studies have found angiotensin II receptor blockers (ARBs) to be more effective in reducing LVH than beta-blockers and data are also available showing their effectiveness in preventing new or recurrent AF, it is reasonable to consider this class of drugs among first line therapies in patients with hypertension and LVH (a very high risk phenotype predisposing to AF) and as adjunctive therapy to antiarrhythmic agents in patients undergoing pharmacological or electrical cardioversion of AF.

Keywords: angiotensin II receptor blockers, left ventricular hypertrophy, atrial fibrillation

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other article by this author:

Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials

Cesare Cuspidi, Francesca Negri, Valentina Giudici, Anna Capra, et al.

Integrated Blood Pressure Control 2009, 2:1-8

Published Date: 26 June 2009

Readers of this article also read:

Curcumin improves prostanoid ratio in diabetic mesenteric arteries associated with cyclooxygenase-2 and NF-κB suppression

Sirada Rungseesantivanon, Naris Thengchaisri, Preecha Ruangvejvorachai, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:421-429

Published Date: 6 December 2010

Effects of telmisartan on office and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care

Frederic Kontny, Terje Risanger, Arne Bye, et al

Vascular Health and Risk Management 2010, 6:31-38

Published Date: 15 January 2010

Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study

Vivencio Barrios, Carlos Escobar, Alberto Calderon, et al

Vascular Health and Risk Management 2009, 5:723-729

Published Date: 27 August 2009

Gelastic seizures associated with hypothalamic hamartomas. An update in the clinical presentation, diagnosis and treatment

José F. Tellez-Zenteno, Cesar Serrano-Almeida, Farzad Moien-Afshari

Neuropsychiatric Disease and Treatment 2008, 4:1021-1031

Published Date: 5 December 2008

Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease

Kjeld Hermansen, Lene Sundahl Mortensen, Marie-Louise Hermansen

Vascular Health and Risk Management 2008, 4:561-574

Published Date: 6 June 2008

A hazardous finding of a rare anomalous left main coronary artery in a patient with a secundum atrial septal defect

Michael Emery, Waqas Ghumman, Shawn Teague, Jo Mahenthiran

Vascular Health and Risk Management 2008, 4:259-262

Published Date: 8 February 2008

Diagnosis and surgical approach of popliteal artery entrapment syndrome: a retrospective study

Stavros Gourgiotis, John Aggelakas, Nikolaos Salemis, Charalabos Elias, Charalabos Georgiou

Vascular Health and Risk Management 2008, 4:83-88

Published Date: 8 February 2008

Therapeutic implications of transesophageal echocardiography after transthoracic echocardiography on acute stroke patients

Tiago Tribolet de Abreu, Sonia Mateus, Cecilia Carreteiro, Jose Correia

Vascular Health and Risk Management 2008, 4:167-172

Published Date: 8 February 2008